Bromodomain Inhibitors: Products

"Bromodomain Inhibitors" has 50 results in Products.
Sort by:
Results Per Page:

MZ 1 

(+)-JQ1 based Degrader (PROTAC®) that selectively degrades BRD4

AT 1 

(+)-JQ1 based PROTAC® with selectivity for BRD4

(+)-JQ1 

Potent and selective BET bromodomain inhibitor; cell permeable

cis MZ 1 

Negative Control for MZ 1 (Cat. No. 6154)

dBRD9 

Potent and selective BRD9 Degrader (PROTAC®)

I-BET 151 dihydrochloride 

BET bromodomain inhibitor; also promotes differentiation of hiPSCs into megakaryocytes

MS 436 

Potent and selective BRD4(1) inhibitor

I-BRD9 

Potent and selective BRD9 inhibitor

Lin28 1632 

RNA binding protein Lin28 inhibitor; promotes mESC differentiation; also bromodomain inhibitor

dBET1 

(+)-JQ1 based Degrader (PROTAC®) targeting BET bromodomains, active in vivo

ZXH 3-26 

Potent and selective BRD4 Degrader (PROTAC®)

LY 303511 

Negative control of LY 294002 (Cat. No. 1130)

XMD 8-92 

ERK5/BMK1 inhibitor; also BRD4 inhibitor

PFI 1 

BET bromodomain inhibitor

Ischemin sodium salt 

CBP inhibitor; cell permeable

Bromosporine 

Broad spectrum bromodomain inhibitor

SGC-CBP30 

Potent CBP/p300 BRD inhibitor

I-CBP 112 

Selective CBP/p300 BRD inhibitor

OXF BD 02 

Selective BRD4(1) inhibitor

PFI 3 

Potent and selective SMARCA2/4 and polybromo 1 inhibitor

BAZ2-ICR 

Selective BAZ2 inhibitor

OF 1 

Selective BRPF1B and BRPF2 inhibitor

CPI 203 

BET bromodomain inhibitor; arrests cell cycle at G1 phase

GSK 5959 

Potent and selective BRPF1 inhibitor

NI 57 

Potent and selective BRPF bromodomain inhibitor

PFI 4 

Potent and selective BRPF1B bromodomain inhibitor

BI 9564 

Potent and selective BRD9 and BRD7 inhibitor; orally active

(-)-JQ1 

Negative control for (+)-JQ1

GSK 2801 

Selective BAZ2A and BAZ2B inhibitor

ISOX DUAL 

Dual BRD4 and CBP/p300 bromodomain inhibitor

ISOX INACT 

Negative control for PF-CBP1

LP 99 

Selective BRD7 and BRD9 inhibitor

ent-LP 99 

Negative Control for LP 99

NVS-CECR2-1 

Potent and selective CECR2 inhibitor

NI 42 

High affinity BRPF inhibitor

BAY 299 

Potent and selective BRD1 and TAF1 inhibitor

TP 472N 

Negative control for TP 472

TP 472 

Potent BRD9/7 inhibitor

TC AC 28 

High affinity BET bromodomain ligand

OTX 015 

BET bromodomain inhibitor; orally bioavailable

GSK 6853 

Potent and selective BRPF1 inhibitor

GSK 9311 hydrochloride 

Negative control for GSK 6853

L Moses dihydrochloride 

High affinity and selective PCAF bromodomain inhibitor

I-BET 762 

Potent and high affinity BET bromodomain inhibitor; anti-inflammatory; orally bioavailable.

TP 238 

CECR2 and BPTF/FALZ inhibitor

VZ 185 

Potent and selective BRD7/9 Degrader (PROTAC®)

cis-VZ 185 

Negative control for VZ 185 (Cat. No. 6936)

dBRD9-A 

Potent BRD9 Degrader (PROTAC®)

dBET6 

Potent and selective (+)-JQ1 based Degrader (PROTAC®) targeting BET bromodomains, active in vivo

ARV 771 

Potent BET bromodomain PROTAC®; also degrades BRD-tagged chimeric antigen receptors (CAR) in T cells
page of 1
Back to Search Results
Apply
FiltersClear All